These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 16404786)
81. Long-acting risperidone in stable patients with schizoaffective disorder. Mohl A; Westlye K; Opjordsmoen S; Lex A; Schreiner A; Benoit M; Bräunig P; Medori R J Psychopharmacol; 2005 Sep; 19(5 Suppl):22-31. PubMed ID: 16144783 [TBL] [Abstract][Full Text] [Related]
82. Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders. Clark I; Taylor D CNS Drugs; 2020 Aug; 34(8):841-852. PubMed ID: 32462508 [TBL] [Abstract][Full Text] [Related]
83. Subacute alteration in level of consciousness in a woman with psychotic depression. Samaan Z; Macqueen G J Psychiatry Neurosci; 2008 May; 33(3):E1-E2. PubMed ID: 18592035 [No Abstract] [Full Text] [Related]
84. Why Is There No Food and Drug Administration-Approved Medication for Major Depression With Psychotic Features? Rothschild AJ J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):359-361. PubMed ID: 34166258 [No Abstract] [Full Text] [Related]
88. Converting From Intramuscular to Oral Risperidone in a Nursing Home Resident. MacNeill BR; Opatrny PM; Burke MS; Heinen LJ; Dysken MW Prim Care Companion CNS Disord; 2023 Jul; 25(4):. PubMed ID: 37506397 [No Abstract] [Full Text] [Related]
89. Maintenance treatment of psychotic depression: Is antipsychotic medication needed? Rothschild AJ Acta Psychiatr Scand; 2024 Jan; 149(1):3-5. PubMed ID: 38086542 [No Abstract] [Full Text] [Related]
90. Risperidone-induced cataract in a young female. Balamurugan R; Gupta PC; Kashyap H; Ram J Indian J Ophthalmol; 2020 Jan; 68(1):214. PubMed ID: 31856527 [No Abstract] [Full Text] [Related]
91. [Farmacotherapeutic treatment of psychotic depression: a review]. Anthonis E; Sienaert P Tijdschr Psychiatr; 2021; 63(5):358-365. PubMed ID: 34043225 [TBL] [Abstract][Full Text] [Related]
92. Optimizing outcomes in major depressive disorder via augmentation therapy--focus on the role of atypical antipsychotics. Foreword. Nelson JC CNS Drugs; 2013 May; 27 Suppl 1():S3-4. PubMed ID: 23709357 [No Abstract] [Full Text] [Related]
93. Free long-acting injectables for patients with psychosis: A step forward. Kong LZ; Shen YT; Zhang DH; Lai JB; Hu SH Asian J Psychiatr; 2023 May; 83():103476. PubMed ID: 36764125 [No Abstract] [Full Text] [Related]
94. Depot risperidone in elderly patients: the experience of an Australian aged psychiatry service. Singh D; O'Connor DW Int Psychogeriatr; 2007 Aug; 19(4):789-92. PubMed ID: 17726767 [No Abstract] [Full Text] [Related]
95. A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II). Diao X; Wang D; Lu S; Hu S; Lai J J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):325-327. PubMed ID: 35221313 [No Abstract] [Full Text] [Related]
96. [Clinical experiences with perphenazine enanthate]. Rafter B Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124 [No Abstract] [Full Text] [Related]
97. Stalking and Huntington's disease: a neurobiological link? Soliman S; Haque S; George E J Forensic Sci; 2007 Sep; 52(5):1202-4. PubMed ID: 17680793 [TBL] [Abstract][Full Text] [Related]